Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.1K
Overview
83.1K
Tissue Transplantation01:24

Tissue Transplantation

810
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
810
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

737
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
737
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.6K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

8.2K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential Impact of the OPTN Status Escalation Policy for Adult Heart Transplant Candidates With Durable LVADs.

Circulation. Heart failure·2026
Same author

High Rate of Transplantation Before Review of Status Exception Requests Among Adult Heart Transplant Candidates.

Circulation. Heart failure·2026
Same author

Benchmarking large language models for cell-free RNA diagnostic biomarker discovery.

Nature communications·2026
Same author

Artifactual declines in durable LVAD utilization among heart transplant candidates: Selection bias in transplant registries.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Ethical Considerations for Heart Organ Allocation: Current Landscape and Future Policy Guidance: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

Impact of Donor Left Ventricular Geometric Remodeling and Hypertrophy on Heart Acceptance and Recipient Survival.

JACC. Heart failure·2026

Related Experiment Video

Updated: Dec 25, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.2K

Adding Insult on Injury: Immunogenic Role for Donor-derived Cell-free DNA?

Shamik Dholakia1, Iwijn De Vlaminck2, Kiran K Khush3

  • 1Oxford Transplant Center, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.

Transplantation
|March 29, 2020
PubMed
Summary

Donor-derived cell-free DNA (dd-cfDNA) signals early solid organ transplant injury. Emerging evidence suggests dd-cfDNA may also trigger inflammation, offering new therapeutic targets and patient stratification strategies.

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.2K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.9K

Related Experiment Videos

Last Updated: Dec 25, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.2K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.2K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.9K

Area of Science:

  • Transplantation immunology
  • Molecular diagnostics

Background:

  • Donor-derived cell-free DNA (dd-cfDNA) is an established early indicator of solid organ transplant injury.
  • The precise role of dd-cfDNA in the post-transplant inflammatory process requires further elucidation.

Purpose of the Study:

  • To review current evidence on the role of dd-cfDNA in solid organ transplantation.
  • To explore the potential of dd-cfDNA as both a biomarker and a mediator of allograft injury and inflammation.

Main Methods:

  • Literature review of recent studies on dd-cfDNA in solid organ transplantation.
  • Analysis of evidence linking dd-cfDNA levels to allograft injury and inflammatory responses.

Main Results:

  • dd-cfDNA serves as an early marker for solid organ transplant injury.
  • Evidence suggests dd-cfDNA may actively trigger inflammation, exacerbating injury.
  • Persistent elevation of dd-cfDNA indicates unresolving molecular injury and identifies at-risk patients.

Conclusions:

  • dd-cfDNA is a significant and continuous biomarker in transplantation.
  • Recognizing dd-cfDNA's dual role opens avenues for novel management strategies and therapeutics.
  • Quantifying interventions based on dd-cfDNA's immunological potential is a promising future direction.